KARIN MADISON: Open Payments
NPI 1922698372 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 6 payments from 5 companies in 2025. Trend: 2023 $373 · 2024 $79 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $147 |
| Amgen Inc. | 1 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $76 |
Products named: LIVTENCITY, TEPEZZA, DUPIXENT, Livdelzi.
Industry payments across TX — which companies pay providers there.
